東陽光(600673.SH):公司所持東陽光藥2.26億股內資股已轉換為H股流通股上市流通
格隆匯 9 月 16日丨東陽光(600673.SH)公告,公司委託宜昌東陽光長江藥業股份有限公司(以下簡稱“東陽光藥”)辦理將公司所持有東陽光藥22620萬股內資股股份轉換為境外上市股份並在香港聯交所主板上市流通相關事宜(以下簡稱“本次股份轉換”)。經向中國證券監督管理委員會(以下簡稱“中國證監會”)提出H股全流通申請,東陽光藥於2020年6月2日收到了中國證監會下發的正式批覆文件,核准東陽光藥股東廣東東陽光科技控股股份有限公司所持226,200,000股境內未上市股份轉為境外上市股份,批覆自核準之日起12個月有效。2020年8月18日,經向香港聯交所上市委員會申請,東陽光藥獲得香港聯交所出具的上市批准,批准226,200,000股H股上市及買賣。
取得226,200,000股轉換H股上市及買賣批准後,東陽光藥根據有關規定辦理了股份上市及登記存管程序,該等股份於2020年9月3日上午九點開始在香港聯交所上市。根據有關規定,該等股份由香港中央結算(代理人)有限公司作為最終名義持有人列示於東陽光藥的股東名冊,在完成持有明細維護後境內參與股東方可通過名義持有人進行股份交易結算。
2020年9月16日,經向中國證券登記結算有限責任公司深圳分公司(以下簡稱“中國結算”)申請,東陽光藥獲得中國結算予以確認,完成了證券持有明細的初始維護及其他交易結算安排程序,公司取得了享有上述轉換H股權益的合法證明。截至目前,本次股份轉換程序已全部實施完成,公司所持有的東陽光藥2.26億股內資股股份已轉換為H股流通股上市流通,併合法享有該等股份的權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.